Open Letter to ViewRay Customers, Service, Software Engineers and Suppliers—Let's Preserve ViewRay Technology
Letter to ViewRay Lenders/Investment Bankers and Customers From Krishnan Suthanthiran, President/Founder of TeamBest Global Companies
Open Letter to ViewRay Customers From Krishnan Suthanthiran, President/Founder of TeamBest Global Companies
ViewRay® Announces Commencement of Nasdaq Delisting Proceedings: Common Stock Expected to Begin Trading on the OTC Markets
Why Is ViewRay (VRAY) Stock Down 69% Today?
ViewRay® Files Voluntary Chapter 11 Petitions
VA Oklahoma City Healthcare System Chooses ViewRay's MRIdian® MRI-Guided Radiation Therapy System
Top 5 Health Care Stocks That Could Blast Off In May - Coherus BioSciences (NASDAQ:CHRS), Intercept Pharma (NASDAQ:ICPT)
ViewRay's MRIdian® to be Featured at Leading European Radiation Oncology Meeting
ViewRay (VRAY) Reports Q1 Loss, Misses Revenue Estimates
ViewRay Announces First Quarter 2023 Results
ViewRay: Shares Crater As Company Warns Of Slower Growth, Higher Cash Burn
ViewRay Announces Preliminary First Quarter 2023 Results and Updated Fiscal Year 2023 Financial Guidance; Company to Explore Strategic Alternatives to Maximize Shareholder Value
ViewRay Announces Conference Call for Preliminary First Quarter 2023 Financial Results to be held Pre-Market opening on April 13, 2023
Penny Stocks To Buy Now? 7 With Unusual Options Volume This Week
GenesisCare Launches ViewRay MRIdian® MRI-Guided Radiation Therapy System at Lee Health Regional Cancer Center, Empowering Cancer Patient Care with an Innovative Radiotherapy Approach with Reduced Side Effects, Fewer Sessions Needed
Military University Hospital Prague Selects ViewRay's MRIdian® MRI-Guided Radiation Therapy System to Treat Cancer Patients
Siteman Cancer Center at Washington University Treats 2,000th Patient with MRIdian® MRI-Guided Radiation Therapy
ViewRay, Inc. (VRAY) Q4 2022 Earnings Call Transcript
ViewRay (VRAY) Reports Q4 Loss, Misses Revenue Estimates
ViewRay Announces Fourth Quarter and Full Year 2022 Results
ViewRay: Sales, Order Momentum Ratcheting Higher
ViewRay Announces Conference Call for Fourth Quarter 2022 Financial Results to be Held After Market on February 27, 2023
ViewRay Enters into Cooperation Agreement with Hudson Executive Capital
Findings Published in JAMA Oncology Demonstrate Superiority of MRIdian® MRI-Guidance in Stereotactic Body Radiotherapy (SBRT) for Localized Prostate Cancer
ViewRay Announces Preliminary Fourth Quarter and Full Year 2022 Results; appoints William P. "Bill" Burke as Chief Financial Officer
Chindex Medical Acquires 10 ViewRay MRIdian® Systems for Advanced Cancer Treatment
University Hospitals in Cleveland Enters into Master Purchase Agreement with ViewRay for Multiple MRIdian® Systems
ViewRay: Revise Thesis To Buy, Multiple Upside Targets In Place
ViewRay Expands Access to Non-Dilutive Capital With New Debt Facility
ViewRay® to Participate in the 34th Annual Piper Sandler Healthcare Conference
ViewRay® to Present at the Stifel 2022 Healthcare Conference
ViewRay, Inc. (VRAY) Q3 2022 Earnings Call Transcript
ViewRay (VRAY) Reports Q3 Loss, Tops Revenue Estimates
ViewRay Announces Third Quarter 2022 Results
MIRAGE Phase III Randomized Controlled Trial Demonstrates Superiority of MRIdian® MRI-Guidance in Stereotactic Body Radiotherapy (SBRT) for Localized Prostate Cancer
ViewRay Announces Primary Endpoint Outcome from First Prospective, Multi-Institutional Study to Deliver Ablative Doses of Radiation to Pancreatic Cancer Patients
MRIdian Clinical Studies and Initial MRIdian A3i Clinical Experience to be Highlighted at ASTRO 2022
ViewRay Launches Phase III Pancreatic Cancer Study to Demonstrate Superior Overall Survival for Patients Receiving MRI-guided Ablative Radiation Therapy
ViewRay Announces Conference Call for Third Quarter 2022 Financial Results to be Held After Market on November 1, 2022
SUNY Upstate Cancer Center Chooses ViewRay's MRI-Guided Radiation Therapy System to Treat Cancer Patients
San Pietro Fatebenefratelli Hospital Treats its 1,000th Patient with MRIdian® MRI-Guided Radiation Therapy
ViewRay to host Investor Day
MD Anderson Cancer Center Selects ViewRay to Expand MR-Guided Radiation Therapy Program
ViewRay® to Present at the Morgan Stanley 20th Annual Global Healthcare Conference
GenesisCare Purchases Two Additional ViewRay MRIdian MRI-guided Radiotherapy Systems for Guildford and Birmingham Projects, Doubling United Kingdom Footprint to Four Systems
ViewRay Announces China NMPA Approval of its MRIdian® MRI-Guided Radiation Therapy for Cancer Patients
VA Houston Healthcare System Selects ViewRay to Expand Advanced Radiation Therapy Services
National Cancer Center Hospital in Tokyo Upgrades to MRIdian® Linac for MRI-Guided Radiation Therapy and has treated its first patients
ViewRay Selects Denver for Headquarters